Cannabis can induce a clinical response in patients with Crohn's disease

被引：0
|
作者：
Attwood, Claire
机构：
来源：
EXPERT REVIEW OF CLINICAL IMMUNOLOGY | 2013年 / 9卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1009 / 1009
页数：1
相关论文
共 50 条
  • [21] CT Enterography Correlation With Clinical Response to Therapy in Patients Affected by Crohn's Disease
    Scaldaferri, Franco
    Laterza, Lucrezia
    Minordi, Laura Maria
    Pizzoferrato, Marco
    Forte, Fabrizio
    Lopetuso, Loris Riccardo
    Gerardi, Viviana
    Pecere, Silvia
    Poscia, Andrea
    Larosa, Luigi
    Bonomo, Lorenzo
    Gasbarrini, Antonio
    GASTROENTEROLOGY, 2012, 142 (05) : S341 - S341
  • [22] Ultrasonographic assessment of Crohn's disease patients: can be easier and more affordable for clinical practice?
    Les, Anda
    Dimitriu, Anca
    Costache, Roxana
    Gheorghe, Liana
    Gheorghe, Cristian
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2019, 28 (01) : 130 - 131
  • [23] ILEAL BIOMARKER OF INNATE IMMUNE ACTIVATION CAN PREDICT CLINICAL RESPONSE TO VEDOLIZUMAB IN CROHN'S DISEASE
    Osterman, Mark T.
    Gordon, Ilyssa O.
    Davis, Elisabeth M.
    Ciorba, Matthew A.
    Glover, Sarah C.
    Abraham, Bincy P.
    Khan, Freeha
    Shen, Bo
    Yee, Eric
    Allard, Felicia
    Liu, Julia J.
    GASTROENTEROLOGY, 2019, 156 (03) : S59 - S60
  • [24] ILEAL BIOMARKER OF INNATE IMMUNE ACTIVATION CAN PREDICT CLINICAL RESPONSE TO VEDOLIZUMAB IN CROHN'S DISEASE
    Osterman, Mark T.
    Gordon, Ilyssa O.
    Davis, Elisabeth M.
    Ciorba, Matthew A.
    Glover, Sarah C.
    Abraham, Bincy P.
    Khan, Freeha
    Shen, Bo
    Yee, Eric
    Allard, Felicia
    Liu, Julia J.
    INFLAMMATORY BOWEL DISEASES, 2019, 25 : S41 - S41
  • [25] Predictors of response to infliximab in patients with Crohn's disease
    Parsi, MA
    Achkar, JP
    Richardson, S
    Katz, J
    Hammel, JP
    Lashner, BA
    Brzezinski, A
    GASTROENTEROLOGY, 2002, 123 (03) : 707 - 713
  • [26] Microinflammation in patients with Crohn's disease in clinical remission
    Maharshak, Nitsan
    Zilberman, Liaz
    Arbel, Yaron
    Shapira, Itzhak
    Berliner, Shlomo
    Arber, Nadir
    Dotan, Iris
    JOURNAL OF CROHNS & COLITIS, 2008, 2 (04): : 310 - 314
  • [27] Clinical response to the canakinumab in crohn’s disease related artrhritis
    Zübeyde Gündüz
    Ruhan Düşünsel
    Duran Aslan
    Betül Sözeri
    Ayşenur Paç Kısaarslan
    Pediatric Rheumatology, 12 (Suppl 1)
  • [28] Treatment of Crohn's Disease with Cannabis: An Observational Study
    Naftali, Timna
    Bar Lev, Lihi
    Yablekovitz, Doron
    Half, Elisabeth
    Konikoff, Fred M.
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2011, 13 (08): : 455 - 458
  • [29] An overview of cannabis based treatment in Crohn's disease
    Naftali, Timna
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 14 (04) : 253 - 257
  • [30] Anti-infliximab antibody concentrations can guide treatment intensification in patients with Crohn's disease who lose clinical response
    Dreesen, E.
    Van Stappen, T.
    Ballet, V.
    Peeters, M.
    Compernolle, G.
    Tops, S.
    Van Steen, K.
    Van Assche, G.
    Ferrante, M.
    Vermeire, S.
    Gils, A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (03) : 346 - 355
12345